Le cancer du sein touche une femme sur 9 au cours de sa vie en Amérique du Nord. Il s’agit d’une maladie hétérogène et il est important d’adapter les traitements au profil biologique de la tumeur. Le but de ce projet est de développer une méthode d’analyse d’échantillons de tumeurs mammaires basée sur 300 marqueurs […]

  In recent years, the interest given to disease biomarkers has boomed. Biotechnology and pharmaceutical companies are exploring ways to use biomarkers to speed up the drug development process, as well as to rapidly assess a diseases state, staging, progression and response to therapy. Multiple reaction monitoring (MRM) Mass Spectrometry (MS) has been shown to […]

In recent years, the interest given to disease biomarkers has boomed. Biotechnology and pharmaceutical companies are exploring ways to use biomarkers to speed up the drug development process, as well as to rapidly assess  diseases state, staging, progression and response to therapy. Multiple reaction monitoring (MRM) Mass Spectrometry (MS) has been shown to be well […]